Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amino Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic route for amino alcohol intermediates reduces waste and improves chirality. Reliable supply chain partner for scalable pharmaceutical manufacturing.
Patent CN101472877A details a scalable route for chiral amino alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN1077565C reveals a robust Zr-Ni-Cu-Mo catalyst for amino alcohol amination, offering superior selectivity and supply chain stability for pharma intermediates.
Patent CN1891683A reveals a high-pressure Mannich route for N-monosubstituted beta-ketoamines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112852894A reveals SpAmDH mutant for high-purity chiral amino alcohol. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN1075055C details a novel one-pot reduction of amino acids to amino alcohols using unactivated borohydrides, offering significant cost reduction and high chiral purity for pharmaceutical manufacturing.
Patent CN1665773A reveals a high-yield pressurized Mannich route for N-monosubstituted beta-amino alcohols, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.
Patent CN1678562A details a Rh-catalyzed method for high-purity amino alcohols, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN111499524B reveals a green photochemical route for aminoalcohol intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Patent CN117105802B enables one-step amino alcohol synthesis. Reduces complexity in pharmaceutical intermediates manufacturing with high purity and green conditions.
Patent CN1360574A reveals a scalable route for tricyclic aminoalcohol derivatives using Ru-catalysis, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN1360574A details a novel route for tricyclic aminoalcohol derivatives featuring asymmetric reduction. This process offers significant cost reduction and improved supply chain reliability for pharmaceutical manufacturing.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
Patent CN110550992A reveals green photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.